Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses.

Molecular oncology - 1 Mar 2015

Abbasi M Reza, Rifatbegovic Fikret, Brunner Clemens, Ladenstein Ruth, Ambros Inge M, Ambros Peter F

Abstract excerpt

Neuroblastoma is the most common extra-cranial solid tumor in childhood. Presence of disseminated tumor cells (DTCs) in the bone marrow (BM) at diagnosis and at relapse is a common event in stage M neuroblastomas. Although the clinical heterogeneity of disseminated neuroblastomas is frequently associated with genomic diversity, so far, only little information exists about the genomic status of DTCs. This lack of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Neoplasm
Share to Bone Marrow
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Freezing

Share to Genome, Human

Share to Neoplastic Cells, Circulating

Share to Neuroblastoma

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 25467309
DOI: 10.1016/j.molonc.2014.10.010
PMCID: PMC5528711

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses.PMID 25467309Read ↗

Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progressionSemantic proximity Read ↗

The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic ApproachesSemantic proximity Read ↗

Metastatic tumor cells in bone marrow differ from paired neuroblastoma tumor and contain subsets with therapy-resistant characteristicsSemantic proximity Read ↗

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeSemantic proximity Read ↗

Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomesSemantic proximity Read ↗

Tumoral heterogeneity in neuroblastomaSemantic proximity Read ↗

Global genomic and RNA profiles for novel risk stratification of neuroblastoma.Semantic proximity Read ↗

Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.Semantic proximity Read ↗

The Past, Present and Future of Flow Cytometry in Central Nervous System MalignanciesSemantic proximity Read ↗

Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA ProfilingSemantic proximity Read ↗

5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk NeuroblastomaSemantic proximity Read ↗

Using droplet digital PCR to analyzeMYCNandALKcopy number in plasma from patients with neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.